Before I get started, I hold fairly large option positions on this stock. Reason being, I honestly believe it's one of the most promising investments I've ever found.The first reason is an already approved drug (omidria) which is better than it's competitors and, showing rapid growth (26%quarter over quarter). So with this already existing drug alone a very good investment. What makes this an unlimited upside investment is their pipeline of drugs . Two current phase 3 trials for treatments of rare diseases. Each of these trials have been given either excelerated approval and or fast track approval, with equivelant designation in Europe. Which means that they are in close communications with the FDA and, with positive results shown in these trials approvals will be expedited. If the phase 2 trials are any indication approvals will be coming soon. For one of the trials orphan drug status has been granted. Which essentially means there is no cap on what they can charge for treatments (currently there are dozens of drugs that are hudreds of thousands of dollars, this would be similar). These 2 trials are just the ones closest to approval as you can see in the image above. They have several other very promising drugs in their pipeline.
This company also has only 48 million shares so a rise in revenues is going to greatly effect price of shares.
As always invest at your own risk but, do yourself a favor and, research this very promising company.
Amazing bio-tech company Omeros (omer),set to explode | Ecency
